People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Asana Medical, Inc. | — | Biotechnology | Seed | $2.9M | $64.5M | 2016 |
Gary S. Ramphal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gary S. Ramphal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Reginald Hardy | 1 | 2 |
| Richard C. Bulman, Jr. | 1 | 2 |
| Michael Phalen | 1 | 1 |
| Richard Bulman | 1 | 1 |
| Marc Ramer | 1 | 1 |
| Gerard Coombs | 1 | 1 |
| Gerard S. Coombs | 1 | 1 |
| Christine S. Sapan | 1 | 1 |
| Richard S. Bulman, Jr. | 1 | 1 |
| Gary Ramphal | 1 | 1 |
| Christine Sapan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.